Clinical Trial Update: Pirfenidone to Treat Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of pirfenidone for hypertrophic cardiomyopathy that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED